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Cryptosporidiumhasemergedasanimportantcauseofdiarrhealillnessworldwide,especiallyamongstyoungchildrenandpatients
with infectious or iatrogenic immune deﬁciencies. The authors describe a case of mild cryptosporidiosis in a well-nourished,
immunocompetent, one-year-old child. Rapid clinical and parasitological improvement was observed after a 3-day course of
nitazoxanide.
1.Introduction
Cryptosporidium, a spore-forming protozoon, has been
recognized as a human pathogen since 1976 [1]. The
species most frequently involved in human infections are
Cryptosporidium hominis, which primarily infects humans,
and Cryptosporidium parvum, which infects humans and
animals such as cattle, although infection with unusual
species and genotypes occurs in both immunocompetent
and immunocompromised populations [2]. In immuno-
competent individuals, infection causes self-limited watery
diarrhea. While, in patients with immune deﬁciencies,
cryptosporidiosis may present as chronic or severe life-
threatening diarrhea. In children, mainly those living in
developing countries, cryptosporidiosis can lead to malnu-
trition and developmental delays [3]. Even asymptomatic
infectionsareassociatedwithgrowthdeﬁcits[4].Inindustri-
alized countries, Cryptosporidium also has important public
healthimplications.Cryptosporidiumspp.areknowntocause
traveler’s diarrhea [5] and they are also responsible for
outbreaks of diarrhea, including a memorable outbreak in
Milwaukee, Wisconsin, in 1993 during which nearly 403,000
people developed cryptosporidiosis due to contamination of
drinking water [6]. These outbreaks highlight the medical
importance of cryptosporidiosis. Antimotility drugs play
a key role in the treatment of cryptosporidiosis in both
immunocompetent and immunocompromised individuals,
while the eﬃcacy of antiparasitic drugs in cryptosporidio-
sis remains controversial, particularly in immunocompro-
mised individuals [7]. A recent meta-analysis of trials of
antiparasitic drugs in cryptosporidiosis revealed signiﬁcant
improvement of non-AIDS patients with nitazoxanide, but
no clear evidence of eﬃcacy for other antiparasitic drugs in
cryptosporidiosis or for nitazoxanide in AIDS patients [8].
We describe the clinical and parasitological course of a child
with cryptosporidiosis, who was treated successfully with
nitazoxanide (Alinia, Romark Laboratories).
2.CaseReport
A 16-month-old child was admitted to the pediatrics depart-
ment of Amiens University hospital (France) for diarrheal
syndrome associated with rhinitis. He was born in France
to French parents living in a rural area who had never been
outside of France. The child’s father was a dairy farmer and
his mother did not work on the farm. The child did not
have any particular family history, but had a personal history
of acute otitis media and rhinopharyngitis. His immune
status was not investigated, but on the basis of this history
of frequent rhinitis, a respiratory allergy was suspected and
treated with antihistamine.
The child presented to our institution with a six-day
history of fever, rhinitis, vomiting, and profuse diarrhea. He
experienced up to 7 episodes of nonbloody and nonglairy2 Journal of Parasitology Research
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Figure 1: Ampliﬁcation by nested PCR of Cryptosporidium DNA extracted from stool samples. The gel shows the ampliﬁcation of a speciﬁc
861-bp fragment with speciﬁc primers [9]. Lane M: 123-bp DNA size marker ladder; lanes D01 and D02 (3 days later): samples collected
before treatment; lanes D3–D28: samples collected after treatment; +: positive control; −: negative control.
watery diarrhea per day. He was moderately dehydrated with
very minor signs of dehydration such as weight loss, deep-set
eyes, but no disorders of consciousness. On initial physical
examination, the young patient was afebrile but presented
tachycardia of 124bpm, a respiratory rate of 18/min, and
blood pressure of 82/52mmHg. Oxygen saturation on room
air was 99%. Chest, cardiac, and abdominal examinations
were normal. On ear-nose-throat examination, the tympana
could not be seen due to earwax and the throat was
erythematous. One day after admission, after removal of
earwax, ear examination revealed bilateral acute otitis media.
The patient was placed on intravenous ﬂuids and oral
cefpodoxime was started while waiting for laboratory results.
The laboratory work-up revealed white blood cell
count: 10,200cells/mm3 with 46% neutrophils, 41% lym-
phocytes, 10% monocytes, 3% eosinophils; hemoglobin:
13.3g/dL; platelets: 477,000/mm3. Basophilic lymphoid cells
were observed. Blood biochemistry showed hyponatremia
(130mmol/L) and decreased alkaline reserve (19mmol/L).
Stool specimens were also sent for routine bacterial culture,
rotavirus/adenovirus antigen, Giardia antigen, Clostridium
diﬃcile antigen, and all were negative. Routine stool exami-
nationforentericparasitesincluding directsalinewetmount
examination and two concentration techniques: Bailenger’s
method and MIF (merthiolate iodine formaldehyde) with
both a ﬁxative and a stain was negative. Cryptosporid-
ium antigen was detected in stool by the immunochro-
matographic method (RIDA QUICK Cryptosporidium, R-
biopharm Diagnostic). Modiﬁed Ziehl-Nielsen staining of
a stool smear showed several Cryptosporidium oocysts, up
to 2,400 per gram of stool. Polymerase chain reaction-
restriction fragment length polymorphism (PCR/RFLP) [9]
identiﬁed the species as Cryptosporidium parvum. Three-day
treatment(100mgtwicedaily)withnitazoxanide suspension
(Alinia, Romark Laboratories, FL, USA) was then initiated.
The symptoms resolved on the day after the last dose of nita-
zoxanide. Oocysts were no longer detected in stool using the
modiﬁed Ziehl-Nielsen stain and immunochromatographic
methods, while PCR detection was still weakly positive.
Eradication of oocyst excretion was observed on the day-7
stool sample and PCR detection was also negative (Figure 1).
3. Discussion
Cryptosporidium infections obviously do not represent a
major public health threat in developed countries, although
recurrence of gastrointestinal symptoms due to Cryp-
tosporidium is frequently reported, for example, in the
Milwaukeeoutbreakin1993andinsporadiccasesinEurope.
In most sporadic cases, the source of infection is diﬃcult to
ascertain as many risk factors are commonly encountered
in everyday life. Several factors facilitate transmission of
Cryptosporidium and account for the propensity to cause
large-scale outbreaks of diarrhea. (i) Cryptosporidium can
infect many mammalian species. It is frequently identiﬁed in
farm animals, particularly calves, and in domestic animals;
(ii) theoocystisveryresistant andcanconserveitsinfectivity
in moist environments for a long time; (iii) Cryptosporidium
g e n u si sc o m p o s e do fal a r g en u m b e ro fs p e c i e s ,s e v e r a lo f
which can infect humans; (iv) the infectious dose is very low,
and infected individuals excrete large numbers of oocysts,
up to 108 in a single day [10]. Cryptosporidium oocysts
also remain infectious after being shed and can cause self-
infection. Public health surveys of cases must investigate all
forms of exposure during the two weeks prior to onset of the
illness in order to identify the source of contamination. In
the present case, the child’s father was a dairy farmer and the
family lived 3km from the farm. Two years prior to onset
of the child’s illness, the father reported cryptosporidium-
relatedlossofcalvesinhislivestock.Thechildhadneverbeen
on the farm, and therefore had never had any contact with
the animals. Parasitological stool examinations including
speciﬁc methods for Cryptosporidium oocyst detection of
other family members were negative, although the father
reported occasional gastrointestinal disorders. Cryptosporid-
ium parvum identiﬁed in the child and the documented
presence of Cryptosporidium in the father’s livestock are both
in favour of these animals as the source of contamination,
with transmission via the father. An environmental survey
may have conﬁrmed this hypothesis. As reported elsewhere
[11,12],thiscasereportconﬁrmstheeﬃcacyofnitazoxanide
for the treatment of cryptosporidiosis in immunocompetent
children. Rapid eradication of oocyst excretion was observedJournal of Parasitology Research 3
in this case. However, the role of the child’s immune system
in this rapid clearance of the parasite remains unknown.
The negative result of Cryptosporidium antigen detection
in stool observed immediately after the 3-day course of
nitazoxanide is an interesting ﬁnding, suggesting that the
rapid immunochromatographic method could be used for
posttreatment stool tests instead of more time-consuming
staining or PCR methods.
This case highlights the need to consider spore-forming
protozoa as potential causes of diarrhea in children. Parasite-
related diarrhea in both immunocompetent adults and
children is probably underestimated due to underdiagnosis.
In contrast with bacterial and viral agents, parasites are
less frequently considered by physicians as a potential
cause of diarrhea. Clinical pathologists should therefore
systematicallyperformscreeningforspore-formingprotozoa
in all patients with persistent or acute watery stools.
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